Massachusetts General Hospital

Charlestown HealthCare Center

Charlestown, MA

Sorting 2 by

Accepting patients

TRIlogy-3

A Phase 2, Open-label Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti-CD38 Antibody
Learn more
  • Trispecific Antibody
  • GPRC5D
  • BCMA
  • Phase 2

Accepting patients

ELISA

A Phase 2 Study of Elranatamab in Combination With Isatuximab (ELISA) in Relapsed and Refractory Multiple Myeloma
Learn more
  • T Cell Engager (TCE)
  • Bispecific Antibody
  • BCMA
  • Phase 2
1 hidden based on your filters.Show All